Browsing by Author "Pejušković, Bojana (57212194956)"

Background: Burnout syndrome (BS) and stress-related disorders are frequent among medical specialists, but it has been suggested that some health workers are more prone to the BS than others. This study assessed the intensity of the BS among 3 groups of physicians: psychiatrists, general practitioners and surgeons and examined correlation both between the intensity of BS and physicians' personality dimensions as well as between the level of BS and stress coping strategies. Subjects and methods: The sample consisted of 160 physicians (70 general practitioners, 50 psychiatrists, 40 surgeons). The assessment was carried out by the Maslach Burnout Inventory, The Temperament and Character Inventory and Manual for the Ways of Coping Questionnaire. Results: Dimension of emotional exhaustion was the most prominent in general practitioners (F=5.546, df1=2, df2=156, p<0.01), while dimension of depersonalization was highest in surgeons (F=15.314, df1=2, df2=156, p<0.01), as well as lack of personal accomplishment (F=16.079, df1=2, df2=156, p<0.01). We found that the Harm Avoidance has lead to development of BS while Self-directedness and Cooperativeness were prominent in physicians with low level of BS. The escape-avoidance was in correlation with high depersonalization and lack of personal accomplishment while self-control was prominent in physicians with lower BS. Conclusion: The BS affects personal well-being and professional performance. It is important to identify individuals with a tendency towards its development, in order to undertake preventive measures such as stress management and improvement of the stress coping strategies. © Medicinska naklada.

Introduction/Objective Infertility is the inability to achieve pregnancy after a year or more of unpro-tected sexual intercourse. It is a clinical and social issue affecting both sexes. Infertility can cause anxiety, depression, and personal distress with long-lasting consequences. Men and women tend to cope with infertility in different ways and reliance on certain coping mechanisms can be harmful. This study aims to examine the correlative effects of infertility, distress and depression among couples, and investigate sex disparities in levels of suffering. Methods The research is a cross-sectional study that included 168 participants (84 couples) divided into two groups, control and infertility group. Beck Depression Inventory Second Edition (BDI-II) and the Brief Symptom Inventory (BSI) were used to identify and assess psychological symptoms. Statistical analysis was performed using SPSS at the 0.05 level of significance. Results The results showed that there was a significant difference in the scores on BDI and BSI scales between the infertile and fertile groups, with participants in the infertile group reporting higher levels of depression and distress (t =-2.724, df = 166, p < 0.01; t =-3.609, df = 166, p < 0.01). Women had significantly higher scores on the depression scale than men (t =-2.079, df = 166, p < 0.05). Conclusion In summary, the study found that couples dealing with infertility experience higher levels of distress and depression compared to the control group. Women in these couples are particularly vulnerable to depression. The study highlights the importance of addressing the mental health needs of individuals and couples dealing with infertility, in addition to treating the underlying medical issues. © 2023, Serbia Medical Society. All rights reserved.

Major depressive disorder (MDD) is among the most prevalent psychiatric conditions and a leading cause of disability worldwide. MDD presents a diverse range of symptoms that significantly impact personal, societal, and economic dimensions. Despite the availability of numerous antidepressant treatments (ADTs) targeting different molecular mechanisms, a substantial proportion of patients experience inadequate response, presenting a considerable challenge in MDD management. As a result, adjunctive strategies, particularly involving atypical antipsychotics, are often employed to enhance treatment efficacy. Cariprazine, a D2/D3 partial agonist, is distinguished from other atypical antipsychotics by its selective action on the D3 receptor and its modulation of 5-HT1A, 5-HT2A, and alpha 1B receptors. This distinctive pharmacological profile warrants investigation into its potential effectiveness and tolerability across various symptom domains of MDD, including pleasure, interest, and motivation; mood and suicidality; sleep and appetite; fatigue; psychomotor activity and anxiety; and cognitive function. Preliminary evidence from animal studies and clinical trials suggests that cariprazine may improve motivation, anhedonia, and cognitive function symptoms. Cariprazine shows promise in alleviating mood-related symptoms, though its impact on anxiety and its effects on agitation and psychomotor retardation remains uncertain. Cariprazine may be particularly beneficial for patients with MDD exhibiting anhedonia, cognitive deficits, and possibly fatigue and hypersomnia. Evaluating cariprazine’s efficacy across these symptom domains could reveal patterns that support more personalized treatment approaches for depression. Further research is essential to elucidate the role of cariprazine as an adjunctive therapy for adults with major depressive disorder who have an inadequate response to antidepressant monotherapy. Copyright © 2024 Pejušković, Munjiza Jovanović and Pešić.